156 related articles for article (PubMed ID: 19910023)
1. Placental site trophoblastic tumor: lymphatic spread and possible target markers.
Lan C; Li Y; He J; Liu J
Gynecol Oncol; 2010 Mar; 116(3):430-7. PubMed ID: 19910023
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pathologic characteristics and prognosis of placental site trophoblastic tumor.
Zhao J; Xiang Y; Wan XR; Cui QC; Yang XY
J Reprod Med; 2006 Dec; 51(12):939-44. PubMed ID: 17253041
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
Do NY; Lim SC; Im TS
Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
[TBL] [Abstract][Full Text] [Related]
4. Placental site trophoblastic tumour: clinical features and management.
Hassadia A; Gillespie A; Tidy J; Everard R G N J; Wells M; Coleman R; Hancock B
Gynecol Oncol; 2005 Dec; 99(3):603-7. PubMed ID: 16085293
[TBL] [Abstract][Full Text] [Related]
5. Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: a study of 12 cases.
Nagai Y; Kamoi S; Matsuoka T; Hata A; Jobo T; Ogasawara T; Aoki Y; Ohira S; Okamoto T; Nakamoto T; Kanda K; Matsui H
Gynecol Oncol; 2007 Sep; 106(3):446-52. PubMed ID: 17544490
[TBL] [Abstract][Full Text] [Related]
6. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
[TBL] [Abstract][Full Text] [Related]
7. Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization.
Xue WC; Guan XY; Ngan HY; Shen DH; Khoo US; Cheung AN
Cancer; 2002 Apr; 94(8):2288-94. PubMed ID: 12001129
[TBL] [Abstract][Full Text] [Related]
8. COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL
Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595
[TBL] [Abstract][Full Text] [Related]
9. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
10. Placental site nodule transformed into a malignant epithelioid trophoblastic tumour with pelvic lymph node and lung metastasis.
Tsai HW; Lin CP; Chou CY; Li CF; Chow NH; Shih IM; Ho CL
Histopathology; 2008 Nov; 53(5):601-4. PubMed ID: 18983471
[No Abstract] [Full Text] [Related]
11. Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment.
Hoekstra AV; Keh P; Lurain JR
J Reprod Med; 2004 Jun; 49(6):447-52. PubMed ID: 15283052
[TBL] [Abstract][Full Text] [Related]
12. Placental site trophoblastic tumor arising from antecedent molar pregnancy.
Moore-Maxwell CA; Robboy SJ
Gynecol Oncol; 2004 Feb; 92(2):708-12. PubMed ID: 14766272
[TBL] [Abstract][Full Text] [Related]
13. Chemoresistant placental site trophoblastic tumor with hilar lymph node metastasis: an unusual site of involvement.
Metindir J; Pak I; Ozdilekcan C; Eren E
Gynecol Oncol; 2005 Feb; 96(2):552-5. PubMed ID: 15661251
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
15. Placental site trophoblastic tumor in a postmenopausal female--a case report.
Nigam S; Singhal N; Kumar Gupta S; Chhabra D; Manaktala U
Gynecol Oncol; 2004 May; 93(2):550-3. PubMed ID: 15099979
[TBL] [Abstract][Full Text] [Related]
16. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases.
Wei Q; Sheng L; Shui Y; Hu Q; Nordgren H; Carlsson J
Ann Surg Oncol; 2008 Apr; 15(4):1193-201. PubMed ID: 18172732
[TBL] [Abstract][Full Text] [Related]
17. Management of placental site trophoblastic tumors.
Newlands ES; Bower M; Fisher RA; Paradinas FJ
J Reprod Med; 1998 Jan; 43(1):53-9. PubMed ID: 9475150
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.
Schietroma C; Cianfarani F; Lacal PM; Odorisio T; Orecchia A; Kanitakis J; D'Atri S; Failla CM; Zambruno G
Cancer; 2003 Aug; 98(4):789-97. PubMed ID: 12910524
[TBL] [Abstract][Full Text] [Related]
19. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
Fukunaga S; Maeda K; Noda E; Inoue T; Wada K; Hirakawa K
Oncology; 2006; 71(3-4):204-11. PubMed ID: 17641542
[TBL] [Abstract][Full Text] [Related]
20. Placental site trophoblastic tumor: outcome of five cases including fertility preserving management.
Machtinger R; Gotlieb WH; Korach J; Fridman E; Apter S; Goldenberg M; Ben-Baruch G
Gynecol Oncol; 2005 Jan; 96(1):56-61. PubMed ID: 15589580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
